Advances in HPV Vaccination in People Living with HIV: A Review
Vaccines · 21.02.2026 · 14 (2) · 194
DOI: 10.3390/vaccines14020194 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 21.02.2026. Verfasst von Megan Mooberry und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mark Gilbert and Karen Simmonds Research Gift Fund.
Abstract (Originalsprache)
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and is a leading cause of cervical, anal, penile, and oropharyngeal cancers. This review summarizes the epidemiology of HPV and the immunogenicity, clinical efficacy, and current HPV vaccination recommendations among people living with HIV (PLWH). PLWH experience a disproportionate burden of HPV-related infection and HPV-related malignancies. Although HPV vaccines have been shown to be highly effective, vaccination coverage among PLWH remains suboptimal, particularly in low- and middle-income countries. Barriers to vaccination include extended dosing schedules, limited awareness of the vaccine, and misinformation. Evidence indicates HPV vaccines are safe and induce a robust antibody response in PLWH, especially among individuals with higher CD4+ cell counts and viral suppression on antiretroviral therapy. However, evidence for reduction in clinical HPV-related disease in this population remains limited. Ongoing research is aimed at optimizing the HPV vaccination schedule for PLWH and expanding vaccination in older, high-risk subgroups. Integrating HPV vaccination into HIV care is essential to reduce HPV-related morbidity and mortality in PLWH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
- Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
ORCID-Profile: Megan Mooberry, J Brooks Jackson, Mary B Rysavy
Förderung
- Mark Gilbert and Karen Simmonds Research Gift Fund
Zitieren
APA
Mooberry, M., Jackson, J. B., & Rysavy, M. B. (2026). Advances in HPV Vaccination in People Living with HIV: A Review. Vaccines, 14(2), 194. https://doi.org/10.3390/vaccines14020194
Vancouver
Mooberry M, Jackson JB, Rysavy MB. Advances in HPV Vaccination in People Living with HIV: A Review. Vaccines. 2026;14(2):194. doi:10.3390/vaccines14020194
BibTeX
@article{Mooberry2026,
author = {Mooberry, Megan and Jackson, J Brooks and Rysavy, Mary B},
title = {Advances in HPV Vaccination in People Living with HIV: A Review},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {2},
pages = {194},
doi = {10.3390/vaccines14020194}
}
EUVIMED